Continued support is requested for biochemical studies designed to provide new basic knowledge about proteins responsible for the regulation of the intrinsic coagulation pathway, the kinin-forming pathway and the intrinsic fibrinolytic pathway of plasma. This research proposal addresses basic questions about the initiation and regulation of the contact activation pathways of plasma. The overall strategy of approach is to isolate human plasma proteins that are involved in these pathways, to define relationships between molecular structure and function, and then to study these proteins in plasma experiments in order to define the behavior of these molecules in a physiologic milieu. The long-term objectives of this research project and of the laboratory of the principal investigator involve systematic efforts to elucidate the molecular mechanisms responsible for the regulation of thrombosis and hemostasis. The studies proposed on Factor XII, Factor XI, Factor IX, prekallikrein, high MW kininogen and plasma prourokinase will give new information about the structure and function of these plasma proteins.
The specific aims i n this proposal include studies designed to expand our basic knowledge of the chemical, physical, immunochemical and functional properties of Factors XII, XI, and IX, prekallikrein, high MW kininogen and prourokinase. Experiments are designed to provide further insight to the molecular mechanisms responsible for surface-dependent activation of Factor XII, Factor XI, and prekallikrein. The molecular basis for protein-protein interactions among these plasma components on negatively charged surfaces will be studied. Proteolytic fragments of each of these molecules will be prepared and the expression of functional activity will be related to molecular structure. Abnormal variants of prekallikrein, prekallikrein-Long Beach, and of Factor XII, Factor XII-Bar1, will be isolated and further studied to relate functional abnormalities to structural abnormalities. The recent controversial hypothesis that high MW kininogen, the contact activation cofactor, must be activated by limited proteolysis and subsequently inactivated by proteolysis will be experimentally tested. The contributions of Ca++ ions to the molecular mechanisms responsible for the activation of Factor IX by Factor XIa will be investigated. Quantitative immunoblotting studies of fragments of Factors XII, XI, IX, prekallikrein and high MW kininogen in activated whole plasma will be developed using Western blot techniques. These studies will allow a critical assessment of current concepts and hypotheses for the activation and proteolysis of these proteins in the plasma milieu. The activation of plasma prourokinase by Factor XIIa, Factor XIa, and kallikrein will be studied to help define mechanisms of Factor XII-dependent intrinsic fibrinolysis. It is anticipated that further insights into the molecular mechanisms responsible for contact activation of coagulation, kinin-formation, and fibrinolysis will come from these basic studies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL021544-13
Application #
3336559
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1977-07-01
Project End
1990-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
13
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92037
Deguchi, Hiroshi; Elias, Darlene J; Griffin, John H (2017) Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk. Res Pract Thromb Haemost 1:93-102
Deguchi, Hiroshi; Navarro, Silvia; Payne, Amanda B et al. (2017) Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases. Res Pract Thromb Haemost 1:33-40
Deguchi, Hiroshi; Banerjee, Yajnavalka; Elias, Darlene J et al. (2016) Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism. J Atheroscler Thromb 23:1159-1167
Deguchi, Hiroshi; Sinha, Ranjeet K; Marchese, Patrizia et al. (2016) Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va. Blood 128:1870-1878
Gale, Andrew J; Bhat, Vikas; Pellequer, Jean-Luc et al. (2016) Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding. Pharm Res 33:1517-26
Sinha, Ranjeet K; Yang, Xia V; Fernández, José A et al. (2016) Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier Stabilization. Arterioscler Thromb Vasc Biol 36:518-24
Wang, Yaoming; Zhao, Zhen; Rege, Sanket V et al. (2016) 3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice. Nat Med 22:1050-5
Alsultan, Abdulrahman; Gale, Andrew J; Kurban, Kadijah et al. (2016) Activation-resistant homozygous protein C R229W mutation causing familial perinatal intracranial hemorrhage and delayed onset of thrombosis. Thromb Res 143:17-21
Griffin, John H; Fernández, José A; Lyden, Patrick D et al. (2016) Activated protein C promotes neuroprotection: mechanisms and translation to the clinic. Thromb Res 141 Suppl 2:S62-4
Banno, Fumiaki; Kita, Toshiyuki; Fernández, José A et al. (2015) Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation. Blood 126:2247-53

Showing the most recent 10 out of 139 publications